Atlas Trials

Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection

Clinical trial NCT07332663 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07332663
Sponsor
Sichuan University
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
B Cell Malignancies
Start date
2026-01-01
Primary completion
2027-12-31
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.